Evidence map›Paper›PMID 31867978›Full record

ArticleThe American journal of hospice & palliative care2020

End-of-Life Trajectories of Patients With Hematological Malignancies and Patients With Advanced Solid Tumors Visiting the Emergency Department: The Need for a Proactive Integrated Care Approach.

Mary-Joanne Verhoef, Ellen J M de Nijs, Claudia S Ootjers, Marta Fiocco, Anne J Fogteloo, Christian Heringhaus, Corrie A M Marijnen, Nanda Horeweg, Yvette M van der Linden

Abstract read
In one paragraph

Article in The American journal of hospice & palliative care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Symptom burden and palliative care in patients with hematologic malignancies: a single-center experience.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Clinicians' experiences, perspectives, barriers, and facilitators of integrating palliative care into hematological malignancy care: a qualitative interview study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mary-Joanne VerhoefCenter of Expertise Palliative Care, Leiden University Medical Center, Leiden, the Netherlands.ORCID https://orcid.org/0000-0002-3796-815X
Ellen J M de NijsCenter of Expertise Palliative Care, Leiden University Medical Center, Leiden, the Netherlands.
Claudia S OotjersDepartment of Hematology, Leiden University Medical Center, Leiden, the Netherlands.
Marta FioccoDepartment of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.
Anne J FogtelooDepartment of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Christian HeringhausDepartment of Emergency Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Corrie A M MarijnenDepartment of Radiation Oncology, Leiden University Medical Center, the Netherlands.
Nanda HorewegDepartment of Radiation Oncology, Leiden University Medical Center, the Netherlands.
Yvette M van der LindenCenter of Expertise Palliative Care, Leiden University Medical Center, Leiden, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePatients with hematological malignancies (HM) have more unpredictable disease trajectories compared to patients with advanced solid tumors (STs) and miss opportunities for a palliative care approach. They often undergo intensive disease-directed treatments until the end of life with frequent emergency department (ED) visits and in-hospital deaths. Insight into end-of-life trajectories and quality of end-of-life care can support arranging appropriate care according to patients' wishes.

methodMortality follow-back study to compare of end-of-life trajectories of HM and ST patients who died <3 months after their ED visit. Five indicators based on Earle et al. for quality of end-of-life care were assessed: intensive anticancer treatment <3 months, ED visits <6 months, in-hospital death, death in the intensive care unit (ICU), and in-hospice death.

resultsWe included 78 HM patients and 420 ST patients, with a median age of 63 years; 35% had Eastern Cooperative Oncology Group performance status 3-4. At the ED, common symptoms were dyspnea (22%), pain (18%), and fever (11%). After ED visit, 91% of HM patients versus 76% of ST patients were hospitalized (

conclusionBecause end-of-life care is more aggressive in HM patients compared to ST patients, a proactive integrated care approach with early start of palliative care alongside curative care is warranted. Timely discussions with patients and family about advance care planning and end-of-life choices can avoid inappropriate care at the end of life.

Indexed as

AdultAgedAged, 80 and overEmergency Service, HospitalFemaleHematologic NeoplasmsHospital MortalityHumansMaleMiddle AgedNeoplasmsNetherlandsPalliative CarePatient Care PlanningQuality of LifeTerminal Carecanceremergency departmentend-of-life carehematological malignancypalliative caresupportive care

Identifiers

PMID31867978
PMCPMC7361664

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.